| SNP ID |
Visualize variation |
Clinical significance |
Consequence |
| rs387907190 |
G>A |
Pathogenic |
Non coding transcript variant, coding sequence variant, stop gained |
| rs387907191 |
G>A |
Pathogenic |
Non coding transcript variant, coding sequence variant, stop gained |
| rs587776908 |
C>T |
Pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
| rs1085307575 |
C>T |
Likely-pathogenic |
Stop gained, coding sequence variant, non coding transcript variant |
| rs1085307745 |
ATCT>- |
Pathogenic |
Coding sequence variant, frameshift variant, non coding transcript variant |
| rs1560982564 |
C>G |
Pathogenic |
Intron variant, splice acceptor variant |
| rs1579360593 |
C>T |
Pathogenic |
Non coding transcript variant, stop gained, coding sequence variant |
| rs1579368865 |
T>- |
Pathogenic |
Non coding transcript variant, frameshift variant, coding sequence variant |
| rs1579370234 |
->T |
Likely-pathogenic |
Non coding transcript variant, frameshift variant, coding sequence variant |
| rs1579377990 |
TT>- |
Likely-pathogenic |
Non coding transcript variant, frameshift variant, coding sequence variant |
|
|
UniProt ID
Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
|
Q08J23 |
| Protein name |
RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-me |
| Protein function |
RNA cytosine C(5)-methyltransferase that methylates cytosine to 5-methylcytosine (m5C) in various RNAs, such as tRNAs, mRNAs and some long non-coding RNAs (lncRNAs) (PubMed:17071714, PubMed:22995836, PubMed:31199786, PubMed:31358969). Involved i |
| Family and domains |
Pfam
| Accession |
ID |
Position in sequence |
Description |
Type |
| PF01189 |
Methyltr_RsmB-F |
169 → 369 |
16S rRNA methyltransferase RsmB/F |
Family |
|
| Tissue specificity |
TISSUE SPECIFICITY: Expressed in adult and fetal brain and in lymphoblastoid cells. {ECO:0000269|PubMed:22541559}. |
| Sequence |
|
| Sequence length |
767 |
| Interactions |
View interactions |
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| Autosomal recessive non-syndromic intellectual disability |
Likely pathogenic; Pathogenic |
rs1377452635, rs868442196 |
RCV003331119 RCV003226479 |
| Intellectual disability |
Pathogenic |
rs1579368865 |
RCV004798882 |
| Intellectual disability, autosomal recessive 5 |
Likely pathogenic; Pathogenic |
rs1377452635, rs1403893283, rs2477413153, rs1737230745, rs2477508063, rs2477448485, rs2126481981, rs387907190, rs387907191, rs2126499522, rs587776908, rs1560982564, rs1579370234, rs1579377990, rs1579368865, rs762288077, rs1041431561 View all (2 more) |
RCV001332181 RCV001543353 RCV002283598 RCV002305693 RCV003226540 RCV003223501 RCV003486332 RCV000024355 RCV000024356 RCV000024357 RCV000024358 RCV000030682 RCV000984498 RCV000991432 RCV001027963 RCV003147576 RCV004783922 |
| Phenylketonuria |
Pathogenic |
rs1579368865 |
RCV005860176 |
| See cases |
Likely pathogenic; Pathogenic |
rs1221890051 |
RCV002252421 |
|
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| Cervical cancer |
Benign |
rs10051208, rs76534720 |
RCV005921944 RCV005923425 |
| Cholangiocarcinoma |
Benign |
rs368018490 |
RCV005868262 |
| Chronic lymphocytic leukemia/small lymphocytic lymphoma |
Uncertain significance |
rs202085420 |
RCV005899884 |
| Familial cancer of breast |
Benign; Likely benign |
rs6887702, rs139131959 |
RCV005915664 RCV005869376 |
| Gastric cancer |
Benign; Likely benign |
rs139131959 |
RCV005869377 |
| Intellectual Disability, Recessive |
Conflicting classifications of pathogenicity; Likely benign; Benign; Uncertain significance |
rs8192122, rs147269098, rs200230801, rs139131959, rs779027908, rs886060730, rs8192125, rs139145592, rs4702373, rs562817249, rs569790049, rs8192123, rs8192124, rs778200969 |
RCV000329185 RCV000321887 RCV000385790 RCV000318971 RCV000274142 RCV000380109 RCV000282075 RCV000298290 RCV000355528 RCV000325617 RCV000376517 RCV000365128 RCV000270497 RCV000285782 |
| Lung cancer |
Likely benign; Benign |
rs16877643, rs76534720 |
RCV005915996 RCV005923426 |
| Malignant lymphoma, large B-cell, diffuse |
Benign |
rs368018490 |
RCV005868261 |
| Malignant tumor of esophagus |
Benign |
rs10051208 |
RCV005921943 |
| NSUN2-related disorder |
Benign; Likely benign; Uncertain significance; Conflicting classifications of pathogenicity |
rs13181449, rs184594943, rs150809074, rs143551642, rs140673211, rs527650370, rs141912087, rs756450204, rs181415619, rs147958833, rs138016489 |
RCV003975030 RCV003915155 RCV003958814 RCV003973403 RCV003917762 RCV003967503 RCV003912509 RCV003912508 RCV003912510 RCV003938063 RCV003965478 |
| Ovarian serous cystadenocarcinoma |
Uncertain significance |
rs202085420 |
RCV005899882 |
| Uterine carcinosarcoma |
Benign |
rs13181449 |
RCV005889171 |
| Uterine corpus endometrial carcinoma |
Likely benign; Benign; Uncertain significance |
rs16877643, rs76534720, rs202085420 |
RCV005915997 RCV005923427 RCV005899883 |
|
| Disease Name |
Relationship Type |
References |
| Alzheimer Disease |
Inhibit |
33337366 |
| Aortic Aneurysm Abdominal |
Associate |
34856760 |
| Ataxia Telangiectasia |
Associate |
38183111 |
| Autism Spectrum Disorder |
Associate |
31209396 |
| Breast Neoplasms |
Associate |
40555775 |
| Carcinogenesis |
Associate |
37586363, 38065062 |
| Carcinoma Non Small Cell Lung |
Associate |
37161388 |
| Corneal Diseases |
Associate |
36862118 |
| Developmental Disabilities |
Associate |
33002343 |
| Disease |
Associate |
37226891 |
| Drug Related Side Effects and Adverse Reactions |
Associate |
38183111 |
| Dubowitz syndrome |
Associate |
33098347 |
| Endometrial Neoplasms |
Stimulate |
38042059 |
| Facial Dysmorphism with Multiple Malformations |
Associate |
33002343 |
| Foot Deformities |
Associate |
33002343 |
| Growth Disorders |
Associate |
33002343 |
| Hallux Valgus |
Associate |
33002343 |
| Intellectual Disability |
Associate |
33002343 |
| Leukemia |
Associate |
38065062 |
| Lymphoma |
Associate |
33858292 |
| Lymphoma Non Hodgkin |
Associate |
33400376 |
| Microcephaly |
Associate |
33002343 |
| Neoplasm Metastasis |
Associate |
34504059 |
| Neoplasm Metastasis |
Stimulate |
36632452 |
| Neoplasms |
Associate |
31957540, 34504059, 36169095, 37161388, 37228185, 37769000, 38042059, 38183111, 39742570, 40555775 |
| Osteosarcoma |
Associate |
36792587 |
| Precancerous Conditions |
Associate |
34504059 |
| Prostatic Neoplasms |
Associate |
36169095 |
| Retinoblastoma |
Associate |
37228185 |
| Squamous Cell Carcinoma of Head and Neck |
Associate |
31887619 |
| Stomach Neoplasms |
Stimulate |
34504059 |
| Stomach Neoplasms |
Associate |
37582794 |
| Thyroid Carcinoma Anaplastic |
Associate |
37983928 |
| Thyroid Neoplasms |
Associate |
37983928 |
| Tooth Mobility |
Associate |
33002343 |
| Uterine Cervical Neoplasms |
Associate |
36632452 |
| Uveal melanoma |
Associate |
35757999 |
|